Christer Moller

Title: The Innovations of Christer Moller

Introduction

Christer Moller is a notable inventor based in Tullinge, Sweden. He has made significant contributions to the field of biotechnology, particularly in the production and purification of recombinant arylsulfatase A. With a total of 2 patents, Moller has demonstrated his expertise and commitment to advancing medical science.

Latest Patents

Moller's latest patents focus on the production and purification of recombinant arylsulfatase A. The first patent describes a process for producing recombinant arylsulfatase A in a cell culture system. This process involves culturing a mammalian cell capable of producing rASA in a liquid medium within a system comprising one or more bio-reactors. The invention also details the steps for concentrating, purifying, and formulating rASA through a purification process that includes one or more steps of chromatography. Additionally, the patent outlines a pharmaceutical composition that efficiently endocytoses rASA via the mannose-6-phosphate receptor pathway in vivo. It also discusses the use of rhASA as a medicament for reducing galactosyl sulphatide levels in target cells within the peripheral and central nervous systems.

Career Highlights

Christer Moller is currently associated with Shire Pharmaceuticals Ireland Limited, where he continues to innovate in the field of biotechnology. His work has been instrumental in developing treatments that address critical health issues related to the nervous system.

Collaborations

Moller has collaborated with notable colleagues such as Jens Fogh and Claes Andersson. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christer Moller is a distinguished inventor whose work in biotechnology has led to significant advancements in medical treatments. His patents reflect a deep understanding of complex biological processes and a commitment to improving patient outcomes.